Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4mo2 | FDA | UDP-galactopyranose mutase |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4mo2 | FDA | UDP-galactopyranose mutase | / | 1.000 | |
| 4mo2 | FAD | UDP-galactopyranose mutase | / | 0.621 | |
| 1wam | FAD | UDP-galactopyranose mutase | 5.4.99.9 | 0.550 | |
| 2bi7 | FAD | UDP-galactopyranose mutase | 5.4.99.9 | 0.526 | |
| 3int | FDA | UDP-galactopyranose mutase | 5.4.99.9 | 0.497 | |
| 4rpj | FAD | UDP-galactopyranose mutase | 5.4.99.9 | 0.441 |